Amedeo Smart

Free Medical Literature Service

 

Amedeo

Lung Cancer
  Free Subscription

Articles published in
Int J Oncol
    April 2026
  1. WEI Q, Huang C, Zhang Y, Zeng H, et al
    IL?6: A key player in the EGFR?TKI?resistant tumor microenvironment and its therapeutic implications (Review).
    Int J Oncol. 2026;68:47.
    >> Share

    February 2026
  2. PANG X, Liu H, Long Y, Wang H, et al
    mTOR in radiotherapy of lung cancer: Mechanisms of radiation resistance and therapeutic implications (Review).
    Int J Oncol. 2026;68:21.
    >> Share

  3. GAO J, Mcconnell MJ, Yu B, Li J, et al
    [Expression of Concern] MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion.
    Int J Oncol. 2026;68:16.
    >> Share

    January 2026
  4. LIU L, Yang L, Li H, Shang T, et al
    The tumor microenvironment in lung cancer: Heterogeneity, therapeutic resistance and emerging treatment strategies (Review).
    Int J Oncol. 2026;68:11.
    >> Share

    December 2025
  5. LI X, Wang J, Ge W, Chen X, et al
    Exosomal microRNAs: A new role in the diagnosis and treatment of lung cancer metastases (Review).
    Int J Oncol. 2025;67:101.
    >> Share

    October 2025
  6. WANG F, Hu S, Bian J, Gao Q, et al
    Notch3 mediated TGF?beta1 activation enhances epithelial?mesenchymal transition and cancer stemness in non?small lung cancer.
    Int J Oncol. 2025;67:85.
    >> Share

    August 2025
  7. LI Z, Zhang H, Chen Z, Wu G, et al
    MicroRNA?21: A potential therapeutic target in lung cancer (Review).
    Int J Oncol. 2025;67:67.
    >> Share

    June 2025
  8. WANG SQ, Zhao BX, Liu Y, Wang YT, et al
    [Corrigendum] New application of an old drug: Antitumor activity and mechanisms of doxycycline in small cell lung cancer.
    Int J Oncol. 2025;66:48.
    >> Share

  9. SHEN W, Pang H, Xin B, Duan L, et al
    [Corrigendum] Biological effects of BMP7 on small?cell lung cancer cells and its bone metastasis.
    Int J Oncol. 2025;66:51.
    >> Share

    May 2025
  10. YAN H, He Q, Gao Y, He X, et al
    SLC4A7 suppresses lung adenocarcinoma oncogenesis by reducing lactate transport and protein lactylation.
    Int J Oncol. 2025;66:33.
    >> Share

    April 2025
  11. ZHENG Y, Wang K, Mao W, Zhang G, et al
    Abnormal expression of CDC25C in NSCLC is influenced by transcriptional and RNA N6?methyladenosine?mediated post?transcriptional regulation.
    Int J Oncol. 2025;66:27.
    >> Share

  12. KAEWPIBOON C, Surapinit S, Malilas W, Moon E, et al
    [Retracted] Feroniellin A?induced autophagy causes apoptosis in multidrug?resistant human A549 lung cancer cells.
    Int J Oncol. 2025;66:30.
    >> Share

    March 2025
  13. XI Y, Zeng S, Tan X, Deng X, et al
    Curcumin inhibits the activity of ubiquitin ligase Smurf2 to promote NLRP3?dependent pyroptosis in non?small cell lung cancer cells.
    Int J Oncol. 2025;66:21.
    >> Share

  14. ANDREIKOS D, Spandidos DA, Georgakopoulou VE
    Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review).
    Int J Oncol. 2025;66:23.
    >> Share

    January 2025
  15. KIM H, Jung SH, Jo S, Han JW, et al
    Anti?angiogenic effect of Bryopsis plumosa?derived peptide via aquaporin 3 in non?small cell lung cancer.
    Int J Oncol. 2025;66:5.
    >> Share

  16. WANG Y, Fleishman JS, Li Y, Cao Y, et al
    Non?coding RNA?mediated epigenetic modification of ferroptosis in non?small cell lung cancer (Review).
    Int J Oncol. 2025;66:8.
    >> Share

    November 2024
  17. SUN Y, Lian Y, Mei X, Xia J, et al
    Cinobufagin inhibits M2?like tumor?associated macrophage polarization to attenuate the invasion and migration of lung cancer cells.
    Int J Oncol. 2024;65:102.
    >> Share

    August 2024
  18. ZHANG W, Liu K, Pei Y, Ma J, et al
    [Retracted] Mst1 regulates non?small cell lung cancer A549 cell apoptosis by inducing mitochondrial damage via ROCK1/F?actin pathways.
    Int J Oncol. 2024;65:75.
    >> Share

  19. WU S, Zhao Q, Liu S, Kuang J, et al
    Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non?small cell lung cancer.
    Int J Oncol. 2024;65:77.
    >> Share

    July 2024
  20. TAYLOR J, Dubois F, Bergot E, Levallet G, et al
    Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review).
    Int J Oncol. 2024;65:68.
    >> Share

    June 2024
  21. TAI F, Zhai R, Ding K, Zhang Y, et al
    Long non?coding RNA lung cancer?associated transcript 1 regulates ferroptosis via microRNA?34a?5p?mediated GTP cyclohydrolase 1 downregulation in lung cancer cells.
    Int J Oncol. 2024;64:64.
    >> Share

    April 2024
  22. XIE L, Xie D, Du Z, Xue S, et al
    A novel therapeutic outlook: Classification, applications and challenges of inhalable micron/nanoparticle drug delivery systems in lung cancer (Review).
    Int J Oncol. 2024;64:38.
    >> Share

    March 2024
  23. LI S, Li Z, Huang L, Geng Z, et al
    SLCO4A1, as a novel prognostic biomarker of non?small cell lung cancer, promotes cell proliferation and migration.
    Int J Oncol. 2024;64:30.
    >> Share

  24. WU G, Wang D, Xiong F, Wang Q, et al
    The emerging roles of CEACAM6 in human cancer (Review).
    Int J Oncol. 2024;64:27.
    >> Share

    December 2023
  25. SHIE WY, Chu PH, Kuo MY, Chen HW, et al
    Acidosis promotes the metastatic colonization of lung cancer via remodeling of the extracellular matrix and vasculogenic mimicry.
    Int J Oncol. 2023;63:136.
    >> Share

    November 2023
  26. HU X, Ren J, Xue Q, Luan R, et al
    Anti?PD?1/PD?L1 and anti?CTLA?4 associated checkpoint inhibitor pneumonitis in non?small cell lung cancer: Occurrence, pathogenesis and risk factors (Review).
    Int J Oncol. 2023;63:122.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016